Dr. Pavitra Dewda | Clinical Pharmacology | Best Researcher Award

Dr. Pavitra Dewda, GSK – GlaxoSmithKline, Belgium

Dr. Pavitra Dewda is a seasoned Global Medical Director with over a decade of experience in the pharmaceutical and biotechnology industries, specializing in medical strategy, clinical development, and vaccine lifecycle management. Currently at GlaxoSmithKline, she leads global medical strategies for vaccines, focusing on hepatitis, pertussis, and pneumococcal vaccines. Previously, she held leadership roles at Merck KGaA and Sanofi Pasteur, driving initiatives in medical affairs and scientific engagement. Dr. Dewda has been recognized with multiple global awards for her contributions to vaccine education, regulatory affairs, and medical strategy. 🌍💉💊📈👩‍🔬

Publication Profile

Scopus

Education & Professional Development

Dr. Pavitra Dewda holds an MD from Padmashree Dr. D.Y. Patil University, Pune (2011), and an MBBS from Maharashtra University of Medical Science (2005). Her strong educational foundation in medicine has enabled her to excel in the global pharmaceutical industry. With a passion for medical strategy and vaccine development, Dr. Dewda continues to enhance her expertise through ongoing professional development in clinical affairs, regulatory management, and public health. Her education forms the bedrock for her impactful career in global medical leadership. 🎓💉📚👩‍⚕️

Executive Career Synopsis & Highlights

Dr. Pavitra Dewda is a seasoned global medical leader, currently serving as Global Medical Director at GlaxoSmithKline (GSK) since December 2022. She leads global medical lifecycle accountability for key vaccine portfolios, including hepatitis and pertussis, and drives strategic partnerships, advocacy, and medical strategy. Previously, she was General Manager Medical at GSK India, where she led medical operations, secured regulatory approvals, and executed successful vaccine launches. Dr. Dewda has also held leadership roles at Sanofi and Merck KGaA, excelling in medical affairs, strategic initiatives, and digital transformation, receiving multiple awards for her innovative contributions. 💉🌍🎓

Research Focus

Dr. Pavitra Dewda’s research focuses primarily on vaccinology 🦠💉, infectious diseases 🦠, medical affairs 🩺, and fertility medicine 👶. She has contributed to studies on hepatitis A and B vaccination for at-risk adults in Europe, emphasizing healthcare professionals’ knowledge, attitudes, and practices. Dr. Dewda also co-authored research on vaccinating healthcare providers in India, showcasing the importance of immunization in healthcare settings. Additionally, she has explored fertility treatments 🌱, particularly in in vitro fertilization (IVF) outcomes, demonstrating her expertise in both public health and reproductive health. Her work blends clinical research and medical strategy.

Publication Top Notes

“Knowledge, Attitudes, and Practices of European Healthcare Professionals towards Hepatitis A and Hepatitis B Vaccination in at-Risk Adults” – Vaccines, 2023, 11(11), 1645 🦠💉 | Cited by: 1
“A Modern Perspective on Vaccinating Healthcare Service Providers in India: A Narrative Review” – Infectious Diseases and Therapy, 2022, 11(1), 81–99 🩺💉 | Cited by: 5
“Association between progesterone elevation on the day of human chronic gonadotropin trigger and pregnancy outcomes after fresh embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cycles” – Frontiers in Endocrinology, 2018, 9(APR), 201 👶⚗️ | Cited by: 23

Dr. Nagavendra Kommineni | Pharmacology Award | Best Researcher Award

Dr. Nagavendra Kommineni, Center for Biomedical Research, Population Council, United States

Dr. Nagavendra Kommineni, Ph.D., is a pharmaceutical scientist specializing in formulation development 🧪. With a background from NIPER-Hyderabad, India, he has expertise in designing innovative drug formulations, particularly in topical and transdermal delivery systems 🩺. His work spans nanoparticle-based platforms and sterile manufacturing processes for injectables. Currently a Postdoctoral Research Fellow in New York, he focuses on translational formulations for sexual and reproductive health, including freeze-dried protein formulations and fast-dissolving tablets 🌱. Dr. Kommineni is adept in analytical techniques and actively contributes to GLP and GMP manufacturing standards.

Publication Profile

Google Scholar

Education

Dr. Nagavendra Kommineni holds a Ph.D. in Pharmaceutical Sciences from NIPER-Hyderabad, India (2015-2019). He also earned an M.S (Pharm) in Pharmaceutical Sciences (2012-2014) and a Bachelor of Pharmacy degree from Bapatla College of Pharmacy, India (2008-2012).

Work Experience 🏥

As a Postdoctoral Research Fellow in New York, he pioneers translational formulations for sexual and reproductive health, overseeing formulation development, GLP toxicity studies, and GMP manufacturing. He leads projects on freeze-dried protein formulations and fast-dissolving tablets for HIV and contraception.

Research Focus

Dr. Nagavendra Kommineni’s research primarily focuses on advanced drug delivery systems 🚀, particularly liposomal formulations, nanocarriers, and depot microspheres for targeted therapy. He explores the potential of exosomes and dendrimers in drug delivery, aiming to enhance therapeutic efficacy while minimizing side effects 🎯. His investigations extend to the development of novel formulations for cancer therapy, psoriasis treatment, and overcoming drug resistance in diseases like breast cancer. Through his work, Dr. Kommineni contributes significantly to the advancement of pharmaceutical science, with a particular emphasis on improving patient outcomes through innovative delivery strategies.